Dec. 18, 2020 — With a focus on supporting independent optometry, VSP Global and Essilor have reached an agreement that “further promotes choice for doctors and patients while bolstering a competitive marketplace for their collective stakeholders now and in the future,” according to the companies. 

With this agreement in place, VSP Global will not proceed with changes to its formulary planned for Jan. 1, 2021.

“Because of this agreement, doctors can focus on what is most important to them: patient care. We are all committed to investing in private practice and the choice for doctors to prescribe the lens brands they choose,” says Rick Gadd, president of Essilor North America. 

According to the companies, after extensive efforts from both companies in what has been a difficult year, the two organizations arrived at a solution that will allow each to further reinvest in programs and services that benefit doctors, patients, and, ultimately, the industry.

“By coming together in good faith and seeking common ground, we’re pleased that our organizations have established a positive path forward that benefits our shared stakeholders and the industry we both serve,” says Michelle Skinner, VSP Global chief network officer.